SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-033042
Filing Date
2019-08-27
Accepted
2019-08-26 21:00:07
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q2 2019 isco-10q_20190630.htm 10-Q 2648937
2 EX-31.1 isco-ex311_6.htm EX-31.1 9327
3 EX-31.2 isco-ex312_9.htm EX-31.2 9337
4 EX-32.1 isco-ex321_7.htm EX-32.1 6049
5 EX-32.2 isco-ex322_8.htm EX-32.2 6235
  Complete submission text file 0001564590-19-033042.txt   10206503

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isco-20190630.xml EX-101.INS 2703648
7 XBRL TAXONOMY EXTENSION SCHEMA isco-20190630.xsd EX-101.SCH 56205
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20190630_cal.xml EX-101.CAL 51150
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20190630_def.xml EX-101.DEF 211708
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20190630_lab.xml EX-101.LAB 454631
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20190630_pre.xml EX-101.PRE 356581
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 191054134
SIC: 2834 Pharmaceutical Preparations